Page 795 - ACCCN's Critical Care Nursing
P. 795

772  A P P E N D I X   A   W O R L D   F E D E R AT I O N   O F   C R I T I C A L   C A R E   N U R S E S   P O S I T I O N   S TAT E M E N T S

          7.  Deans  KJ,  Minneci  PC,  Suffredini  AF,  Danner  RL,  Hoffman  WD  et  al.    24.  Luft HS, Bunker JP, Enthoven AC. Should operations be regionalized? The
            Randomization  in  clinical  trials  of  titrated  therapies:  unintended  conse-  empirical relation between surgical volume and mortality. 1979. Clin Orthop
            quences  of  using  fixed  treatment  protocols.  Crit  Care  Med  2007;  35:   Relat Res 2007; 457: 3–9.
            1509–16.                                          25.  Stockwell DC, Slonim AD. Volume-outcome relationships: is it the individual
          8.  Hopewell S, Clarke M, Moher D, Wager E, Middleton P et al. CONSORT for   or the team? Crit Care Med 2006; 34: 2495–7.
            reporting randomized controlled trials in journal and conference abstracts:   26.  Hugonnet S, Chevrolet J-C, Pittet D. The effect of workload on infection risk
            explanation and elaboration. PLOS Med 2008; 5: e20. doi:10.1371/journal.  in critically ill patients. Crit Care Med 2007; 35: 76–81.
            pmed.0050020.                                     27.  Needleman J, Buerhaus P, Mattke S, Stewart M, Zelevinsky K. Nurse-staffing
          9.  GRADE working group. Grading quality of evidence and strength of recom-  levels and the quality of care in hospital. N Engl J Med 2002; 346: 1715–22.
            mendations. Br Med J 2004; 328: 1–8.              28.  Vandijck  DM,  Blot  SI.  High  acuity  nurse  patient  ratio–is  it  costeffective?
         10.  Tinetti ME. Over-the-counter sales of statins and other drugs for asymptom-  In: Kuhlen R, Moreno R, Ranieri M, Rhodes A (eds) Controversies in intensive
            atic conditions. N Engl J Med 2008; 358: 2728–32.    care medicine. Berlin: Medizinisch Wissenschaftiche Verlagsgesellschaft; 2008.
         11.  Armitage  J.  The  safety  of  statins  in  clinical  practice.  Lancet  2007;  370:   p. 393–405.
            1890–1.                                           29.  Needleman J, Buerhaus P. Nurse staffing and patient safety: current knowledge
         12.  Grol R. Beliefs and evidence in changing clinical practice. Br Med J 1997; 315:   and implications for action. Int J Qual Health Care 2003; 15: 275–7.
            418–21.                                           30.  Miranda DR, Ryan DW, Schaufeli WB, Fidler V (eds). Organization and manage-
         13.  Garrow JS. What to do about CAM: how much of orthodox medicine is evi-  ment  of  intensive  care:  a  prospective  study  in  12  European  countries.  Berlin:
            dence based? Br Med J 2007; 335: 951.                Springer; 1997.
         14.  Aronson JK. Anecdotes as evidence. We need guidelines for reporting anec-  31.  Miranda DR, Rivera-Fernández R, Nap RE. Critical care medicine in the hos-
            dotes of suspected adverse drug reactions. Br Med J 2003; 326: 1346.  pital: lessons from the EURICUS-studies. Med Intensiva 2007; 31: 194–203.
         15.  Kelley MA, Angus DC, Chalfin DB, Crandall ED, Ingbar D et al. The critical   32.  Jain M, Miller L, Belt D, King D, Berwick DM. Decline in ICU adverse events,
            care crisis in the United States: a report from the profession. Crit Care Med   nosocomial  infections  and  cost  through  a  quality  improvement  initiative
            2004; 32: 1219–2.                                    focusing on teamwork and culture change. Qual Saf Health Care 2006; 15:
         16.  Pronovost PJ, KJenckes MW, Dorman T, Garrett E, Breslow MJ et al. Organi-  235–9.
            zational characteristics of intensive care units related to outcomes of abdomi-  33.  Baggs JG. Intensive care unit use and collaboration between nurses and physi-
            nal aortic surgery. JAMA 1999; 281: 1310–17.         cians. Heart Lung 1989; 18: 332–8.
         17.  Pronovost P, Angus DC, Dorman T, Robinson KA, Dremsizov TT et al. Physi-  34.  Baggs JG. Nurse–physician collaboration in intensive care units. Crit Care Med
            cian staffing patterns and clinical outcomes in critically ill patients. A system-  2007; 35: 641–2.
            atic review. JAMA 2002; 288: 2151–62.             35.  Prescott PA, Bowen SA. Physician–nurse relationships. Ann Intern Med 1985;
         18.  Amaravadi RK, Dimick JB, Pronovost PJ, Lipsett PA. ICU nurse-to-patient ratio   103: 127–33.
            is associated with complications and resource use after esophagectomy. Inten-  36.  Philpin S. ‘Handing Over’: transmission of information between nurses in an
            sive Care Med 2000; 26: 1857–62,                     intensive therapy unit. Nurs Crit Care 2006; 11: 86–93.
         19.  Valentin A, Capuzzo M, Guidet B, Moreno RP, Dolanski L et al. Patient safety   37.  Donchin Y, Gopher D, Olin M, Badihi Y, Biesky M et al. A look into the nature
            in intensive care: results from the multinational sentinel events evaluation   and causes of human errors in the intensive care unit. Crit Care Med 1995;
            (SEE) study. Intensive Care Med 2006; 32: 1591–8.    23: 294–300.
         20.  Valentin A, Capuzzo M, Guidet B, Moreno R, Metnitz B et al. Errors in the   38.  Le Blanc PM, de Jonge J, de Rijk AE, Schaufeli WE. Well-being of intensive
            administration of parenteral drugs – an urgent safety issue in intensive care   care nurses (WEBIC): a job analytic approach. J Adv Nurs 2001; 36: 460–70.
            units. Results from a multinational, prospective study. Br Med J 2009; 338:   39.  Katona BG, Ayd PR, Walters JK, Caspi M, Finkelstein BW. Effect of a pharma-
            b814.                                                cist’s and a nurse’s interventions on cost of drug therapy in a medical inten-
         21.  Kumar A, Roberts D, Wood KE, Light B, Parrillo JE et al. Duration of hypoten-  sive-care unit. Am J Hosp Pharm 1989; 46: 119–1182.
            sion before initiation of effective antimicrobial therapy is the critical deter-  40.  Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ et al. Pharmacist
            minant  of  survival  in  human  septic  shock.  Crit  Care  Med  2006;  34:   participation on physician rounds and adverse drug events in the intensive
            1589–96.                                             care unit. JAMA 2000; 282: 267–70.
         22.  Garnacho-Montero  J,  Ortiz-Leyba  C,  Herrera-Melero  I,  Aldabó-Pallá  T,   41.  Kane  SL,  Weber  RJ,  Dasta  JF.  The  impact  of  critical  care  pharmacists  on
            Cayuela-Dominguez A et al. Mortality and morbidity attributable to inade-  enhancing patient outcomes. Intensive Care Med 2003; 29: 691–98.
            quate empirical antimicrobial therapy in patients admitted to the ICU with   42.  Rothen HU, Stricker K, Einfalt J, Bauer P, Metnitz PGH et al. Variability in
            sepsis:  a  matched  cohort  study.  J  Antimicrob  Chemother  2008;  61:   outcome and resource use in intensive care units. Intensive Care Med 2007;
            436–41.                                              33: 1329–36.
         23.  Jones J, Rowan K. Is there a relationship between the volume of work carried   43.  Donchin Y, Gopher D, Olin M, Badihi Y, Biesky M et al. A look into the nature
            out in intensive care and its outcome? Int J Technol Assess Health Care 1995;   and causes of human errors in the intensive care unit. Qual Saf Health Care
            11: 762–9.                                           2003; 12: 143–8.
   790   791   792   793   794   795   796   797   798   799   800